Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For DKS
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Weak
33%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -3.87 1.71 1.78
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 21.23 5.99 4.94
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 2.40 33.35 32.57
Cash -8.69 20.46 22.41
Capex 11.69 -1.95 -2.21
Free Cash Flow -87.34 0.92 7.28
Revenue -22.33 37.46 48.23
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 5.43 0.36 0.34
Operating Margin 20.31 0.12 0.10
ROA -2.73 0.03 0.03
ROE -9.55 0.10 0.11
ROIC -0.89 0.06 0.06
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of DKS is permitted for members.
5 Growth
The "Growth Entry" for the Focus of DKS is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of DKS is permitted for members.